Chagas disease: an emerging food-borne entity?

Next year will be the one hundredth anniversary of Carlos Chagas’ discovery of a disease that continues to endanger the lives of a significant number of people in the Americas, despite major successes in controlling its transmission and recent achievements in experimental specific chemotherapy against its etiological agent, Trypanosoma cruzi [1]. Through its impact on worker productivity, premature disability, and death, Chagas disease accounts for 670,000 disability-adjusted life years (DALYs), making it the most noteworthy parasitic disease of the Americas [2]. Furthermore, not only does primary infection continue to endanger the lives of countless people in the region, but the chronic manifestations of Chagas disease also affect the livelihood of many individuals previously infected. As the trend for global migration increases, the scope of Chagas disease threatens to expand exponentially, from rural to urban areas and endemic to non-endemic regions [3].In this epidemiological scenario, a relatively new element in its transmission has been added, the oral transmission. First described in Brazil in 2005 when an outbreak caused several deaths, another 15 cases of the disease followed in Santa Catarina related to the sale and ingestion of sugarcane juice [4,5]. This pattern has been continuing, confirming that oral transmission is not only possible, but more common than previously thought [5]. Since the initial report in 2005, more than a dozen outbreaks of Chagas disease have been recorded in the northern Brazilian states of Para, Amazonas, and Amapa [6]. But now, a confirmed considerable and significant outbreak of Chagas disease in Caracas, Venezuela, also related to ingestion of contaminated beverages [7], further suggests that American Trypanosomiasis is a food-borne entity.One hundred twenty-eight positive cases were confirmed in the Venezuelan capital up to the last week of December 2007. All these cases were clustered in a municipality school [7]. From that total, 12 patients were hospitalized. Patients are receiving benznidazole, one of the approved drugs for the specific treatment of Chagas disease, particularly for acute forms cases like these. Investigations are ongoing at the school given the exposure of 956 individuals [7]. As a consequence of this outbreak, the Ministry of Health, in conjunction with other metropolitan public health, research and academic institutions, produced guidelines for the diagnosis, management and treatment of Chagas disease during the acute phase at health facilities [8].These ongoing outbreaks in Brazil and Venez